SG10201913650WA - Modification of engineered influenza hemagglutinin polypeptides - Google Patents
Modification of engineered influenza hemagglutinin polypeptidesInfo
- Publication number
- SG10201913650WA SG10201913650WA SG10201913650WA SG10201913650WA SG10201913650WA SG 10201913650W A SG10201913650W A SG 10201913650WA SG 10201913650W A SG10201913650W A SG 10201913650WA SG 10201913650W A SG10201913650W A SG 10201913650WA SG 10201913650W A SG10201913650W A SG 10201913650WA
- Authority
- SG
- Singapore
- Prior art keywords
- modification
- influenza hemagglutinin
- hemagglutinin polypeptides
- engineered influenza
- engineered
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662345502P | 2016-06-03 | 2016-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201913650WA true SG10201913650WA (en) | 2020-03-30 |
Family
ID=59093612
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201913650WA SG10201913650WA (en) | 2016-06-03 | 2017-06-02 | Modification of engineered influenza hemagglutinin polypeptides |
SG11201810758WA SG11201810758WA (en) | 2016-06-03 | 2017-06-02 | Modification of engineered influenza hemagglutinin polypeptides |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201810758WA SG11201810758WA (en) | 2016-06-03 | 2017-06-02 | Modification of engineered influenza hemagglutinin polypeptides |
Country Status (14)
Country | Link |
---|---|
US (2) | US11116832B2 (zh) |
EP (1) | EP3464327A1 (zh) |
JP (3) | JP7110119B2 (zh) |
KR (2) | KR20230061583A (zh) |
CN (2) | CN115746107A (zh) |
AU (2) | AU2017275663B2 (zh) |
BR (1) | BR112018075078A2 (zh) |
CA (1) | CA3026094A1 (zh) |
EA (1) | EA201892385A1 (zh) |
IL (1) | IL263416B1 (zh) |
MA (1) | MA45159A (zh) |
MX (2) | MX2018014887A (zh) |
SG (2) | SG10201913650WA (zh) |
WO (1) | WO2017210592A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110106192B (zh) * | 2019-05-23 | 2021-11-12 | 广州医科大学 | 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法 |
CN110106193B (zh) * | 2019-05-23 | 2021-11-12 | 广州医科大学 | 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
ATE420171T1 (de) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
AU760549B2 (en) | 1998-04-03 | 2003-05-15 | University Of Iowa Research Foundation, The | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
WO2005018539A2 (en) | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
CA2598884A1 (en) | 2005-02-24 | 2006-10-05 | University Of Massachusetts | Influenza nucleic acids, polypeptides, and uses thereof |
US9439959B2 (en) | 2006-07-27 | 2016-09-13 | Takeda Vaccines, Inc. | Chimeric influenza virus-like particles |
WO2011044152A1 (en) * | 2009-10-05 | 2011-04-14 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer | Protection against pandemic and seasonal strains of influenza |
KR101262300B1 (ko) * | 2009-10-06 | 2013-05-20 | 헬릭스 주식회사 | 형질전환 식물 유래의 고병원성 조류독감 바이러스 단백질 백신 및 그 제조방법 |
US8883171B2 (en) | 2010-09-14 | 2014-11-11 | University of Pittsburgh—of the Commonwealth System of Higher Education | Computationally optimized broadly reactive antigens for influenza |
AU2012212463B2 (en) | 2011-01-31 | 2016-07-07 | Nanotherapeutics, Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses |
KR20140047069A (ko) | 2011-06-20 | 2014-04-21 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 계산에 최적화된 광범위 반응을 나타내는 h1n1 인플루엔자를 위한 항원 |
EP2758075B1 (en) | 2011-09-20 | 2023-05-03 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
CN103957891B (zh) | 2011-09-23 | 2017-01-11 | 美利坚合众国由健康及人类服务部部长代表 | 基于流感血凝素蛋白的新颖疫苗 |
US9504741B2 (en) * | 2011-11-23 | 2016-11-29 | Vacdiagn Biotechnology Co., Ltd. | Immune methods against influenza viruses and combinatorial vaccines thereof |
EP2812348A4 (en) | 2012-02-07 | 2015-12-30 | Univ Pittsburgh | ANTIGENS WITH BROAD SPECTRUM OPTIMIZED IN SILICO FOR INFLUENZA VIRUSES OF TYPE H3N2, H2N2 AND B |
CN104144941B (zh) * | 2012-02-13 | 2017-06-09 | 高等教育联邦系统-匹兹堡大学 | 以计算方式优化的人和禽h5n1流感的广泛反应性抗原 |
SG11201406153XA (en) * | 2012-03-30 | 2014-10-30 | Univ Pittsburgh | Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses |
IN2015DN03070A (zh) | 2012-11-27 | 2015-10-02 | Univ Pittsburgh | |
AU2013362935B2 (en) | 2012-12-18 | 2018-10-04 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccines and uses thereof |
US20140286981A1 (en) | 2013-03-14 | 2014-09-25 | Wisconsin Alumni Research Foundation | Broadly reactive mosaic peptide for influenza vaccine |
ES2739123T3 (es) | 2013-08-28 | 2020-01-29 | Glaxosmithkline Biologicals Sa | Nuevos antígenos y anticuerpos de la gripe |
-
2017
- 2017-06-02 MA MA045159A patent/MA45159A/fr unknown
- 2017-06-02 SG SG10201913650WA patent/SG10201913650WA/en unknown
- 2017-06-02 WO PCT/US2017/035738 patent/WO2017210592A1/en unknown
- 2017-06-02 SG SG11201810758WA patent/SG11201810758WA/en unknown
- 2017-06-02 CN CN202211086952.0A patent/CN115746107A/zh active Pending
- 2017-06-02 BR BR112018075078-6A patent/BR112018075078A2/pt unknown
- 2017-06-02 EP EP17731970.4A patent/EP3464327A1/en active Pending
- 2017-06-02 MX MX2018014887A patent/MX2018014887A/es unknown
- 2017-06-02 KR KR1020237014598A patent/KR20230061583A/ko not_active Application Discontinuation
- 2017-06-02 IL IL263416A patent/IL263416B1/en unknown
- 2017-06-02 US US16/306,325 patent/US11116832B2/en active Active
- 2017-06-02 CN CN201780048571.4A patent/CN109563138B/zh active Active
- 2017-06-02 CA CA3026094A patent/CA3026094A1/en active Pending
- 2017-06-02 AU AU2017275663A patent/AU2017275663B2/en active Active
- 2017-06-02 KR KR1020197000100A patent/KR102529010B1/ko active IP Right Grant
- 2017-06-02 EA EA201892385A patent/EA201892385A1/ru unknown
- 2017-06-02 JP JP2018563423A patent/JP7110119B2/ja active Active
-
2018
- 2018-11-30 MX MX2023008256A patent/MX2023008256A/es unknown
-
2020
- 2020-05-29 JP JP2020094356A patent/JP2020141703A/ja not_active Withdrawn
-
2021
- 2021-08-12 US US17/400,390 patent/US11904012B2/en active Active
-
2022
- 2022-03-04 AU AU2022201514A patent/AU2022201514B2/en active Active
- 2022-08-01 JP JP2022122751A patent/JP7479424B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
SG11201810758WA (en) | 2018-12-28 |
AU2017275663B2 (en) | 2021-12-09 |
MX2018014887A (es) | 2019-06-06 |
MA45159A (fr) | 2019-04-10 |
CA3026094A1 (en) | 2017-12-07 |
CN115746107A (zh) | 2023-03-07 |
AU2022201514B2 (en) | 2024-02-15 |
MX2023008256A (es) | 2023-07-19 |
JP2022153591A (ja) | 2022-10-12 |
US11116832B2 (en) | 2021-09-14 |
JP2020141703A (ja) | 2020-09-10 |
EP3464327A1 (en) | 2019-04-10 |
KR20230061583A (ko) | 2023-05-08 |
EA201892385A1 (ru) | 2019-06-28 |
IL263416A (en) | 2019-01-31 |
CN109563138A (zh) | 2019-04-02 |
JP7479424B2 (ja) | 2024-05-08 |
CN109563138B (zh) | 2022-09-23 |
US20220054623A1 (en) | 2022-02-24 |
KR20190039065A (ko) | 2019-04-10 |
US20200215182A1 (en) | 2020-07-09 |
KR102529010B1 (ko) | 2023-05-04 |
WO2017210592A1 (en) | 2017-12-07 |
IL263416B1 (en) | 2024-06-01 |
JP7110119B2 (ja) | 2022-08-01 |
US11904012B2 (en) | 2024-02-20 |
AU2017275663A1 (en) | 2018-12-13 |
AU2022201514A1 (en) | 2022-03-24 |
JP2019525733A (ja) | 2019-09-12 |
BR112018075078A2 (pt) | 2019-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257480A1 (zh) | 工程病毒 | |
PL3148578T3 (pl) | Stabilizowane trimery regionu łodygi hemaglutyniny grypy i ich zastosowania | |
HK1243925A1 (zh) | 針對流感血球凝集素的結合分子及其用途 | |
IL252659B (en) | Human antibodies to influenza hemagglutinin | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
ZA201808246B (en) | Improvement of hpv l2 peptide immunogenicity | |
SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
HU4602U (en) | Set of saggar assembly | |
PT3218033T (pt) | Nebulização de líquidos | |
EP3528827A4 (en) | INFLUENZA HEMAGGLUTININ PROTEIN Vaccines | |
HK1254342A1 (zh) | 流感效力試驗 | |
IL263416A (en) | Modification of transgenic influenza hemagglutinin polypeptides | |
IL248055B (en) | Preparations of multimeric influenza proteins with multiple epitopes and their preparation | |
IL249500A0 (en) | Reno vaccine system of influenza vaccine component | |
HU4603U (en) | Set of saggar assembly | |
EP3423090C0 (en) | NOVEL INFLUENZA ANTIGENS | |
PT3430390T (pt) | Origem molecular da alergia | |
GB201622143D0 (en) | Modification of polypeptides | |
IL249705B (en) | Influenza virus vaccines and their uses | |
IL249704A0 (en) | Influenza virus vaccines and their uses | |
AU201615441S (en) | A part of a spray bottle | |
TWM534222U (en) | Improvement of support-reinforced scaffolding plate | |
GB201600382D0 (en) | Engineered virus | |
HK1205852A2 (zh) | 種新型的香水噴霧器 | |
IL231286B (en) | Secure device to a railing made of fragile material |